Artia Global Partners’s Ascendis Pharma A/S ASND Stock Holding History

Artia Global Partners’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.73M	Hold	17,740	–	–	0.87%	27
2026 Q1	$4.06M	Hold	17,740	–	–	0.81%	23
2025 Q4	$3.78M	Buy	17,740 +5,500	+45%	+$1.14M	0.54%	30
2025 Q3	$2.43M	Hold	12,240	–	–	0.39%	30
2025 Q2	$2.11M	Buy	12,240 +4,800	+65%	+$782K	0.51%	23
2025 Q1	$1.16M	Hold	7,440	–	–	0.29%	30
2024 Q4	$1.02M	Hold	7,440	–	–	0.37%	35
2024 Q3	$1.11M	Hold	7,440	–	–	0.3%	33
2024 Q2	$1.01M	Sell	7,440 -8,454	-53%	-$1.15M	0.2%	35
2024 Q1	$2.4M	Buy	+15,894	New	+$2.27M	0.48%	23

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Artia Global Partners's ASND Position: Q2 2026 in Review

Artia Global Partners held its Ascendis Pharma A/S (ASND) position steady in Q2 2026 at 17,740 shares worth $4.73M. The position accounts for 0.87% of the portfolio, ranked #27.

Artia Global Partners first reported a position in ASND in Q1 2024 and has held it in 10 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Artia Global Partners held 17,740 shares of Ascendis Pharma A/S worth $4.73M as of Q2 2026.
Artia Global Partners left its Ascendis Pharma A/S share count unchanged in Q2 2026.
Ascendis Pharma A/S made up 0.87% of Artia Global Partners's portfolio in Q2 2026, its #27 holding.
Artia Global Partners first reported a position in Ascendis Pharma A/S in Q1 2024 and has held it in 10 quarters since.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Artia Global Partners's 13F filing for Q2 2026, filed 14 Aug 2026.